These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29552550)

  • 41. Intravenous thrombolysis for stroke increases over time at primary stroke centers.
    Prabhakaran S; McNulty M; O'Neill K; Ouyang B
    Stroke; 2012 Mar; 43(3):875-7. PubMed ID: 22135073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Personalized Prehospital Triage in Acute Ischemic Stroke.
    Venema E; Lingsma HF; Chalos V; Mulder MJHL; Lahr MMH; van der Lugt A; van Es ACGM; Steyerberg EW; Hunink MGM; Dippel DWJ; Roozenbeek B
    Stroke; 2019 Feb; 50(2):313-320. PubMed ID: 30661502
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does a 'code stroke' rapid access protocol decrease door-to-needle time for thrombolysis?
    Tai YJ; Weir L; Hand P; Davis S; Yan B
    Intern Med J; 2012 Dec; 42(12):1316-24. PubMed ID: 22212180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011.
    Lubeck DP; Danese MD; Duryea J; Halperin M; Tayama D; Yu E; Lalla D; Grotta JC
    Int J Stroke; 2016 Feb; 11(2):198-205. PubMed ID: 26783311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determinants of early outcomes in patients with acute ischemic stroke and proximal artery occlusion.
    LaBuzetta JN; Yoo AJ; Ali S; Fitzpatrick K; Leslie-Mazwi T; Hirsch JA; Schwamm L; Rost N
    J Stroke Cerebrovasc Dis; 2014; 23(10):2527-2532. PubMed ID: 25238927
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Burden of stroke in Italy: an economic model highlights savings arising from reduced disability following thrombolysis.
    Chiumente M; Gianino MM; Minniti D; Mattei TJ; Spass B; Kamal KM; Zimmerman DE; Muca A; Luda E
    Int J Stroke; 2015 Aug; 10(6):849-55. PubMed ID: 25854294
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Social History Matters-The Impact of Illicit Drug Use on tPA Use and In-Hospital Mortality in Acute Ischemic Stroke.
    Marx MH; Albright KC; Shaban A; Boehme AK; Beasley TM; Martin-Schild S
    Int Neuropsychiatr Dis J; 2014 May; 2(3):127-135. PubMed ID: 25436216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety Outcomes After Thrombolysis for Acute Ischemic Stroke in Patients With Recent Stroke.
    Merkler AE; Salehi Omran S; Gialdini G; Lerario MP; Yaghi S; Elkind MSV; Navi BB
    Stroke; 2017 Aug; 48(8):2282-2284. PubMed ID: 28679847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.
    Xian Y; Federspiel JJ; Grau-Sepulveda M; Hernandez AF; Schwamm LH; Bhatt DL; Smith EE; Reeves MJ; Thomas L; Webb L; Bettger JP; Laskowitz DT; Fonarow GC; Peterson ED
    JAMA Neurol; 2016 Jan; 73(1):50-9. PubMed ID: 26551916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. International benchmarking for acute thrombolytic therapy implementation in Australia and Japan.
    Kawano H; Levi C; Inatomi Y; Pagram H; Kerr E; Bivard A; Spratt N; Miteff F; Yonehara T; Ando Y; Parsons M
    J Clin Neurosci; 2016 Jul; 29():87-91. PubMed ID: 26928157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Victorian Stroke Telemedicine Project: implementation of a new model of translational stroke care for Australia.
    Bladin CF; Moloczij N; Ermel S; Bagot KL; Kilkenny M; Vu M; Cadilhac DA;
    Intern Med J; 2015 Sep; 45(9):951-6. PubMed ID: 26011155
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trial application of a Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS) to assist priority setting in stroke.
    Moodie ML; Carter R; Mihalopoulos C; Thrift AG; Chambers BR; Donnan GA; Dewey HM
    Stroke; 2004 May; 35(5):1041-6. PubMed ID: 15031457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness analysis of mechanical thrombectomy plus tissue-type plasminogen activator compared with tissue-type plasminogen activator alone for acute ischemic stroke in France.
    Kaboré N; Marnat G; Rouanet F; Barreau X; Verpillot E; Menegon P; Maachi I; Berge J; Sibon I; Bénard A
    Rev Neurol (Paris); 2019 Apr; 175(4):252-260. PubMed ID: 30642680
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States.
    Demaerschalk BM; Yip TR
    Stroke; 2005 Nov; 36(11):2500-3. PubMed ID: 16224087
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of educational television commercial on pre-hospital delay in patients with ischemic stroke.
    Nishijima H; Kon T; Ueno T; Haga R; Yamazaki K; Yagihashi K; Funamizu Y; Arai A; Suzuki C; Nunomura JI; Baba M; Tomiyama M
    Neurol Sci; 2016 Jan; 37(1):105-109. PubMed ID: 26306697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.
    Heuschmann PU; Berger K; Misselwitz B; Hermanek P; Leffmann C; Adelmann M; Buecker-Nott HJ; Rother J; Neundoerfer B; Kolominsky-Rabas PL; ;
    Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12663875
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Observational study of telephone consults by stroke experts supporting community tissue plasminogen activator delivery.
    Majersik JJ; Meurer WJ; Frederiksen SA; Sandretto AM; Xu Z; Goldman EB; Scott PA
    Acad Emerg Med; 2012 Sep; 19(9):E1027-34. PubMed ID: 22978729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protocol Deviations before and after Treatment with Intravenous Tissue Plasminogen Activator in Community Hospitals.
    Adelman EE; Scott PA; Skolarus LE; Fox AK; Frederiksen SM; Meurer WJ
    J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):67-73. PubMed ID: 26419527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.